Regeneron (NASDAQ: REGN) is a leading science and technology company delivering life-transforming medicines for serious diseases.

Founded by physician-scientists nearly 30 years ago, their science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases.

In addition to their medicines, their innovations include the VelociSuite®technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world and rapid response technologies being used for global good.

Leadership

Their leadership team possesses rich and diverse industry knowledge, a passion for science and a shared commitment to help transform lives.

Made up of their founding scientists, industry experts, Nobel Laureates and members of the National Academy of Sciences, they consistently push the boundaries of scientific excellence and discovery.